These reports extend from a hypothesized role for STAT3 in the immunopathology of COVID-19 through the IL-6 amplifier pathway, whereby STAT3 and NFκB synergize to drive inflammatory gene transcription locally in non-immune tissue, driving inflammation-mediated tissue injury [51]. This evidence concerns the gene STAT3 and COVID-19.